JAYNAH MISTRY: Open Payments
NPI 1568915015 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,221 in 95 payments from 39 companies in 2025. Trend: 2023 $2,228 · 2024 $1,880 · 2025 $2,221
Food & beverage: $2,221
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $266 |
| Merck Sharp & Dohme LLC | 11 | $240 |
| Novartis Pharmaceuticals Corporation | 13 | $239 |
| ABBVIE INC. | 4 | $100 |
| Daiichi Sankyo Inc. | 3 | $83 |
| BeOne Medicines USA, Inc. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 2 | $69 |
| Genmab U.S., Inc. | 2 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
Products named: KEYTRUDA, KISQALI, DARZALEX, BRUKINSA, LUTATHERA, JEMPERLI, Epkinly, Doptelet.
Industry payments across MD — which companies pay providers there.
